Dysregulation of extracellular matrix and Lysyl Oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts
Abstract Background Ehlers-Danlos syndrome Type IV (aka Vascular Ehlers Danlos, or vEDS) is a dominantly inherited mutation in the Collagen 3A1 gene (COL3A1). The disease is characterized by tissue friability and age-related susceptibility to arterial aneurysm, dissection and rupture as well as uter...
Main Authors: | Reece Foehr, Keith Anderson, Owen Dombrowski, Anna Foehr, Erik D. Foehr |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-023-03007-7 |
Similar Items
-
Lysyl oxidase inhibitors in colorectal cancer progression
by: Muxian Liu, et al.
Published: (2025-02-01) -
Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress
by: Carme Ballester-Servera, et al.
Published: (2024-04-01) -
Lysyl Oxidase Mediates Proliferation and Differentiation in the Esophageal Epithelium
by: Kanak V. Kennedy, et al.
Published: (2024-12-01) -
Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic EsophagitisSummary
by: Masaru Sasaki, et al.
Published: (2024-01-01) -
Properties of a cryptic lysyl oxidase from haloarchaeon Haloterrigena turkmenica
by: Nikolay B. Pestov, et al.
Published: (2019-04-01)